These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 23247950)

  • 1. Summaries for patients. Adalimumab for the treatment of hidradenitis suppurativa.
    Ann Intern Med; 2012 Dec; 157(12):I-50. PubMed ID: 23247950
    [No Abstract]   [Full Text] [Related]  

  • 2. Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial.
    Kimball AB; Kerdel F; Adams D; Mrowietz U; Gelfand JM; Gniadecki R; Prens EP; Schlessinger J; Zouboulis CC; van der Zee HH; Rosenfeld M; Mulani P; Gu Y; Paulson S; Okun M; Jemec GB
    Ann Intern Med; 2012 Dec; 157(12):846-55. PubMed ID: 23247938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy.
    Arenbergerova M; Gkalpakiotis S; Arenberger P
    Int J Dermatol; 2010 Dec; 49(12):1445-9. PubMed ID: 21091684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotational therapy with TNF-alpha blockers for recalcitrant hidradenitis suppurativa.
    Brunasso AM; Massone C
    Eur J Dermatol; 2010; 20(5):644-6. PubMed ID: 20615818
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term successful adalimumab therapy in severe hidradenitis suppurativa.
    Blanco R; Martínez-Taboada VM; Villa I; González-Vela MC; Fernández-Llaca H; Agudo M; González-López MA
    Arch Dermatol; 2009 May; 145(5):580-4. PubMed ID: 19451504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective open-label clinical trial of efficacy of the every week administration of adalimumab in the treatment of hidradenitis suppurativa.
    Sotiriou E; Goussi C; Lallas A; Chovarda E; Apalla Z; Lazaridou E; Ioannides D
    J Drugs Dermatol; 2012 May; 11(5 Suppl):s15-20. PubMed ID: 22644772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa.
    van Rappard DC; Leenarts MF; Meijerink-van 't Oost L; Mekkes JR
    J Dermatolog Treat; 2012 Aug; 23(4):284-9. PubMed ID: 21756155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
    Harde V; Mrowietz U
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate to severe hidradenitis suppurativa treated with biological therapies.
    Chinniah N; Cains GD
    Australas J Dermatol; 2014 May; 55(2):128-31. PubMed ID: 24456051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of moderate to severe hidradenitis suppurativa.
    Kimball AB; Gu Y; Okun M
    Ann Intern Med; 2013 Jul; 159(1):72-3. PubMed ID: 23817710
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of moderate to severe hidradenitis suppurativa.
    Prasad V
    Ann Intern Med; 2013 Jul; 159(1):72. PubMed ID: 23817709
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors: An update on infliximab.
    Brunasso AM; Massone C
    Acta Derm Venereol; 2011 Jan; 91(1):70-1. PubMed ID: 21103830
    [No Abstract]   [Full Text] [Related]  

  • 13. Flexural or inverse psoriasis in a patient with hidradenitis suppurativa receiving treatment with infliximab.
    Nuño-González A; Dehesa L; Ricotti C; Kerdel F
    Actas Dermosifiliogr; 2012 Dec; 103(10):936-7. PubMed ID: 23149048
    [No Abstract]   [Full Text] [Related]  

  • 14. Current and emerging nonsurgical treatment options for hidradenitis suppurativa.
    Kerdel FA
    Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S57-9. PubMed ID: 25188460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hidradenitis suppurativa: are tumour necrosis factor-alpha blockers the ultimate alternative?
    Brunasso AM; Delfino C; Massone C
    Br J Dermatol; 2008 Sep; 159(3):761-3. PubMed ID: 18627370
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa.
    Miller I; Lynggaard CD; Lophaven S; Zachariae C; Dufour DN; Jemec GB
    Br J Dermatol; 2011 Aug; 165(2):391-8. PubMed ID: 21457202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hidradenitis suppurativa managed with adalimumab.
    Yamauchi PS; Mau N
    J Drugs Dermatol; 2009 Feb; 8(2):181-3. PubMed ID: 19213236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hidradenitis suppurativa with biological therapy: report of four cases and review of the literature.
    Bahillo Monné C; Honorato Guerra S; Schoendorff Ortega C; Gargallo Quintero AB
    Dermatology; 2014; 229(4):279-87. PubMed ID: 25472035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition.
    Saraceno R; Babino G; Chiricozzi A; Zangrilli A; Chimenti S
    J Am Acad Dermatol; 2015 Jan; 72(1):e42-4. PubMed ID: 25497954
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of adalimumab in recalcitrant hidradenitis suppurativa.
    Sotiriou E; Apalla Z; Vakirlis E; Ioannides D
    Eur J Dermatol; 2009; 19(2):180-1. PubMed ID: 19153066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.